PIAS1 and posterior cortical atrophy: In our comprehensive expression studies we evaluated PIAS1 levels in non-cancerous prostate tissues, primary tumors of different grades and stages, metastatic lesions, and chemotherapy-treated tumor specimens (217 tissue samples in total), as well as in parental and docetaxel resistant PCa cell lines.